We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+24.67%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$2.69B
AUM Growth
+$1.03B
Cap. Flow
+$315M
Cap. Flow %
11.73%
Top 10 Hldgs %
29.64%
Holding
1,627
New
613
Increased
235
Reduced
298
Closed
420

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$120M
2
CRM icon
Salesforce
CRM
+$95.5M
3
AMZN icon
Amazon
AMZN
+$92.9M
4
META icon
Meta Platforms (Facebook)
META
+$47.2M
5
PHYS icon
Sprott Physical Gold
PHYS
+$41.6M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$26.9M
2
UN
Unilever NV New York Registry Shares
UN
+$11.5M
3
PTK.U
PTK Acquisition Corp. Units, each consisting of one share of Common Stock, and one Warrant to acquir
PTK.U
+$8.72M
4
BSN.U
Broadstone Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of on
BSN.U
+$8.47M
5
EOSE icon
Eos Energy Enterprises
EOSE
+$7.76M

Sector Composition

Rank Sector Weight
1 Technology 11.88%
2 Consumer Discretionary 11.69%
3 Healthcare 6.76%
4 Financials 6.41%
5 Communication Services 5.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLU
1176
DELISTED
BELLUS Health Inc.
BLU
$72K ﹤0.01%
23,677
– –
KALA icon
1177
KALA BIO
KALA
$13.6M
$68K ﹤0.01%
4
-17
-81% -$320K
AP.WS
1178
DELISTED
Ampco-Pittsburgh Corp Series A Warrants
AP.WS
$65K ﹤0.01%
11,936
-33,764
-74% -$19.3K
UUUU icon
1179
Energy Fuels
UUUU
$3.11B
$64K ﹤0.01%
+15,000
New +$33.8K
PHAS
1180
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$58K ﹤0.01%
+17,176
New +$61.5K
AKBA icon
1181
Akebia Therapeutics
AKBA
$346M
$54K ﹤0.01%
19,332
-1,288
-6% -$3.76K
GIX.RT
1182
DELISTED
GigCapital2, Inc. Rights, each exchangeable into one-twentieth of a share of Common Stock
GIX.RT
$52K ﹤0.01%
126,120
-273,880
-68% -$83.9K
WHWK
1183
Whitehawk Therapeutics
WHWK
$201M
$49K ﹤0.01%
3,346
-24,382
-88% -$521K
VIRX
1184
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$43K ﹤0.01%
+6,114
New +$31.9K
TPST icon
1185
Tempest Therapeutics
TPST
$14.6M
$30K ﹤0.01%
71
– –
CARM
1186
DELISTED
Carisma Therapeutics
CARM
$27K ﹤0.01%
+1,000
New +$25.4K
SLNO
1187
DELISTED
Soleno Therapeutics
SLNO
$25K ﹤0.01%
+861
New +$24.8K
SYBX
1188
DELISTED
Synlogic
SYBX
$24K ﹤0.01%
+746
New +$23.8K
FENG
1189
Phoenix New Media
FENG
$17.5M
$23K ﹤0.01%
3,135
– –
CRBP icon
1190
Corbus Pharmaceuticals
CRBP
$177M
$18K ﹤0.01%
+490
New +$18.3K
CREXW
1191
DELISTED
Creative Realities, Inc. Warrant
CREXW
$16K ﹤0.01%
12,236
– –
BXRX
1192
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$14K ﹤0.01%
10
– –
TLGT
1193
DELISTED
Teligent, Inc
TLGT
$10K ﹤0.01%
13,369
– –
AAL icon
1194
PUT
American Airlines Group
AAL
$11B
– –
-500
Closed -$615K
ACAD icon
1195
PUT
Acadia Pharmaceuticals
ACAD
$4.93B
– –
-132
Closed -$545K
ACHC icon
1196
Acadia Healthcare
ACHC
$3B
– –
-7,800
Closed -$230K
ACI icon
1197
Albertsons Companies
ACI
$5.75B
– –
-21,028
Closed -$291K
ADNWW
1198
DELISTED
Advent Technologies Holdings Warrant
ADNWW
– –
-56,802
Closed -$587K
ADP icon
1199
CALL
Automatic Data Processing
ADP
$107B
– –
-109
Closed -$1.52M
ADT icon
1200
ADT
ADT
$5.63B
– –
-48,656
Closed -$398K
46 47
48
49 50

Similar funds

MAM
Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
IMCOOI
Investment Management Corp of Ontario (IMCO) Toronto, Canada $7.76B AUM 99.29% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

Boothbay Fund Management's Q4 2020 Portfolio in Review

As of Q4 2020, Boothbay Fund Management held 1,627 positions worth $2.69B, up 63% from $1.65B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Boothbay Fund Management deployed $315M of net new capital in Q4 2020, opening 613 new positions and adding to 235 existing holdings. Its largest new stake was Sprott Physical Gold: 2,799,997 shares worth $42.3M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $26.9M trimmed.

  • Boothbay Fund Management's largest Q4 2020 buy was Sprott Physical Gold: 2,799,997 shares worth $42.3M.
  • Boothbay Fund Management added most to Alibaba in Q4 2020, an estimated $120M increase.
  • Boothbay Fund Management's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $26.9M.
  • Boothbay Fund Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $11.5M.
  • Boothbay Fund Management's ten largest holdings make up 30% of its $2.69B portfolio in Q4 2020.
  • Boothbay Fund Management opened 613 new positions and closed 420 in Q4 2020.
  • Boothbay Fund Management's portfolio value rose 63% quarter-over-quarter to $2.69B.

Based on Boothbay Fund Management's 13F filing for Q4 2020, filed 12 Feb 2021.